Huyck, Julia Jones
We investigate why some people are better than others at perceiving, and learning to perceive, basic auditory and speech sounds.
Kim, Min-Ho
We investigate the use of nanotechnology for the treatment of diseases including multidrug-resistant bacterial infections, non-healing chronic wounds, and Alzheimer’s disease.
Raman, Priya
We investigate cellular and molecular mechanisms responsible for accelerated vascular complications in diabetes and obesity. We also study the role of cerebrovascular dysfunction in Alzheimer’s disease-related pathology and cognitive impairment in metabolic disorders.
Grider-Potter, Neysa
My lab focuses on the locomotor function of the mammalian head and neck and how their functions may influence craniovertebral form.
Clements, Robert
We develop and apply different 3D imaging and computational techniques to understand diseases of the brain, for virtual and physical reconstruction as well as education.
German, Rebecca
We investigate the potential interactions that exist between biomechanics and neurophysiology. Her ultimate goals are to (1) enhance our knowledge of dysfunction as the basis for developing rehabilitation strategies, particularly for children and (2) explicate the evolutionary basis of mammalian feeding functional morphology.
Chen, Yeong-Renn
We investigate the disease mechanisms underlying myocardial infarction and heart failure using rodent models. Our research focuses on how mitochondrial dysfunction, caused by oxygen toxicity and free radical injury, contributes to the pathophysiology of heart disease.
Baker, Kenneth
We investigate the therapeutic potential of neuromodulation-based approaches to the treatment of neurological disorders.
Matsuoka, Ryota
We investigate the genetic mechanisms responsible for vascular heterogeneity, specializations, and integrity in the central nervous system with the goal to correct vascular and neural abnormalities in neurological diseases.
Kasumov, Takhar
Our laboratory applies high-throughput unbiased system biology approaches, i.e. metabolomics and proteomics to understand the pathogenesis of obesity-associated metabolic diseases, including nonalcoholic fatty liver disease (NAFLD) and diabetes, and their cardiovascular complications. Our group helped to develop the heavy water-based metabolic labeling approach for global proteome dynamics studies, which are currently extensively used by multiple research labs around the world. NAFLD and type 2 diabetes (T2D) afflict one-third of the US’s population.